GlassScriptPhysician profile
Rosa C Roman
NPI 1720160567
$880.30
in general payments reported to CMS, 2019-2025
10 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $109 · 2021: $243 · 2022: $120 · 2023: $14.60 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $254.49 | 2019-2023 | Collagenase Santyl |
| Alkermes, INC. | $147.73 | 2019-2025 | Aristada, Aristada Initio |
| Trilliant Surgical LLC. | $138.59 | 2025 | Minimally Invasive Bunion Plate, Left |
| Organogenesis INC. | $136.86 | 2019-2021 | |
| Cardiovascular Systems INC. | $92.11 | 2022 | |
| Merck Sharp & Dohme LLC | $26.96 | 2019 | |
| Orthofix Medical, INC. | $23.92 | 2025 | Physio-Stim |
| Integra Lifesciences Corporation | $23.52 | 2021 | |
| Kci USA, INC. | $20.42 | 2020 | |
| Paragon 28, INC. | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosa Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.